Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 29, 2024
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
[ Mon, Jul 29th 2024
] - WOPRAI
Matthew Harrison Maintained (TSVT) at Hold with Decreased Target to $6 on, Jul 29th, 2024
Matthew Harrison of Morgan Stanley, Maintained "2seventy bio, Inc." (TSVT) at Hold with Decreased Target from $7 to $6 on, Jul 29th, 2024.
Matthew has made no other calls on TSVT in the last 4 months.
There are 3 other peers that have a rating on TSVT. Out of the 3 peers that are also analyzing TSVT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Reiterated at Hold and Held Target at $5 on, Thursday, June 27th, 2024
These are the ratings of the 2 analyists that currently disagree with Matthew
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $11 on, Thursday, May 9th, 2024
- Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Increased Target to $12 on, Monday, April 8th, 2024
